Mitsuo Hori, MD from Ibaraki Prefectural Central Hospital discusses results of randomized trial of ELd treatment and primary endpoint was met with ORR of 88 with ELd in Japanese patients at the 2017 American Society of Hematology.
Results of Randomized Trial of ELd Treatment – Primary endpoint was met with ORR of 88with ELd in Japanese patients
